Skip to main content

Table 1 Infusion study: induction of anaesthesia and recovery times

From: First administration to man of Org 25435, an intravenous anaesthetic: A Phase 1 Clinical Trial

 

Median

Min

Max

Mean effect site concn[SD]

n

2 mg kg-1 (n = 2)

Time in minutes

μg mL-1

 

Cessation of speech

0.9

0.8

0.9

6.2

2

Eye closure

0.9

0.8

0.9

6.2

2

Syringe drop

    

0

Loss of eyelash reflex

1.7

1.7

1.7

10.9

1

Eyes open on command

2.1

2

2.2

8.3

2

Limb movement on command

2.1

2

2.2

8.3

2

3 mg kg-1 (n = 5)

     

Cessation of speech

0.8

0.5

0.9

8.3 [2.5]

5

Eye closure

0.8

0.8

1.1

10.3 [1.6]

5

Syringe drop

0.9

0.8

1.3

10.5 [1.5]

3

Loss of eyelash reflex

1.1

0.9

1.3

11.8 [2.1]

5

Eyes open on command

3.3

3.3

5.3

5.9 [1.3]

5

Limb movement on command

4.1

3.3

6.4

5.4 [1.4]

5

4 mg kg-1 (n = 5)

     

Cessation of speech

0.7

0.5

0.8

8.0 [1.4]

5

Eye closure

0.7

0.7

0.8

9.5 [0.7]

5

Syringe drop

0.9

0.7

1.2

12.2 [2.0]

5

Loss of eyelash reflex

1.2

1

2

15.5 [2.6]

5

Eyes open on command

5.3

3.2

9.2

6.4 [1.1]

5

Limb movement on command

5.8

3.7

9.4

6.1 [0.9]

5

  1. Mean effect site concentration is the averaged individualised model predicted value of Org25435 in the biophase at time for each event.